Home
>
National Drug Code (NDC)
>
Glycopyrrolate
Glycopyrrolate - 10019-016-02 - (Glycopyrrolate)
Drug Information of Glycopyrrolate
| Product NDC: | 10019-016 |
| Proprietary Name: | Glycopyrrolate |
| Non Proprietary Name: | Glycopyrrolate |
| Active Ingredient(s): | .2 mg/mL & nbsp; Glycopyrrolate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Glycopyrrolate
| Product NDC: | 10019-016 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017558 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101217 |
Package Information of Glycopyrrolate
| Package NDC: | 10019-016-02 |
| Package Description: | 10 VIAL, MULTI-DOSE in 1 PACKAGE (10019-016-02) > 20 mL in 1 VIAL, MULTI-DOSE (10019-016-29) |
NDC Information of Glycopyrrolate
| NDC Code | 10019-016-02 |
| Proprietary Name | Glycopyrrolate |
| Package Description | 10 VIAL, MULTI-DOSE in 1 PACKAGE (10019-016-02) > 20 mL in 1 VIAL, MULTI-DOSE (10019-016-29) |
| Product NDC | 10019-016 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glycopyrrolate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20101217 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | GLYCOPYRROLATE |
| Strength Number | .2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
